Total Payments
$490.69
2024 Payments
$16.79
Companies
8
Transactions
22
Medicare Patients
1,382
Medicare Billing
$113,787
Payment Breakdown by Category
Food & Beverage$490.69 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $490.69 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $209.82 | 6 | $0 (2022) |
| PFIZER INC. | $73.30 | 5 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $51.59 | 3 | $0 (2022) |
| Lilly USA, LLC | $43.05 | 2 | $0 (2022) |
| Grifols USA, LLC | $34.03 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $33.78 | 2 | $0 (2022) |
| Allergan Inc. | $23.81 | 1 | $0 (2018) |
| Biogen, Inc. | $21.31 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.79 | 1 | Grifols USA, LLC ($16.79) |
| 2023 | $30.72 | 2 | Grifols USA, LLC ($17.24) |
| 2022 | $149.80 | 8 | Lilly USA, LLC ($43.05) |
| 2021 | $21.31 | 1 | Biogen, Inc. ($21.31) |
| 2019 | $36.28 | 2 | Avanir Pharmaceuticals, Inc. ($18.94) |
| 2018 | $205.72 | 6 | Amgen Inc. ($159.74) |
| 2017 | $30.07 | 2 | Avanir Pharmaceuticals, Inc. ($15.22) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Immunology and Neurology | ||||||
| 07/07/2023 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Immunology and Neurology | ||||||
| 02/13/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2022 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Neuroscience | ||||||
| 10/28/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Bone Health | ||||||
| 10/03/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $23.43 | General |
| 06/28/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/06/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/14/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/22/2021 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| 06/12/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Bone Health | ||||||
| 02/07/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/06/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: Endocrinology | ||||||
| 08/28/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Endocrinology | ||||||
| 05/08/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: VACCINES | ||||||
| 04/19/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Endocrinology | ||||||
| 04/12/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/03/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/01/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 46 | $13,064 | $2,508 |
| 2022 | 9 | 376 | 536 | $143,063 | $38,105 |
| 2021 | 7 | 375 | 547 | $135,033 | $36,230 |
| 2020 | 8 | 585 | 825 | $142,156 | $36,944 |
Total Patients
1,382
Total Services
1,954
Medicare Billing
$113,787
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 28 | $8,960 | $1,869 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $4,104 | $638.64 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 134 | 244 | $70,150 | $16,726 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 62 | 89 | $35,037 | $9,328 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 34 | 34 | $9,534 | $4,445 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 40 | 50 | $10,500 | $2,450 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $9,055 | $2,115 | 23.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2022 | 23 | 31 | $3,057 | $1,269 | 41.5% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2022 | 12 | 17 | $3,786 | $1,264 | 33.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Facility | 2022 | 27 | 27 | $972.00 | $253.20 | 26.0% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2022 | 27 | 27 | $972.00 | $253.20 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 169 | 309 | $79,936 | $20,748 | 26.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 79 | 99 | $35,937 | $8,759 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 19 | 19 | $5,016 | $2,544 | 50.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 47 | 52 | $9,488 | $2,480 | 26.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2021 | 25 | 32 | $3,360 | $1,355 | 40.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Facility | 2021 | 18 | 18 | $648.00 | $171.90 | 26.5% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2021 | 18 | 18 | $648.00 | $171.90 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 201 | 339 | $73,563 | $17,288 | 23.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 97 | 123 | $18,327 | $4,682 | 25.5% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Facility | 2020 | 112 | 157 | $12,239 | $4,103 | 33.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 39 | 46 | $9,623 | $2,949 | 30.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 29 | 33 | $9,603 | $2,657 | 27.7% |
| 99487 | Complex chronic care management services 60 minutes clinical staff time | Facility | 2020 | 41 | 53 | $9,085 | $2,290 | 25.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 40 | 47 | $6,854 | $1,825 | 26.6% |
About Dr. Raphael Balbino, M.D
Dr. Raphael Balbino, M.D is a Integrative Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1972894921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raphael Balbino, M.D has received a total of $490.69 in payments from pharmaceutical and medical device companies, with $16.79 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($490.69).
As a Medicare-enrolled provider, Balbino has provided services to 1,382 Medicare beneficiaries, totaling 1,954 services with total Medicare billing of $113,787. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Integrative Medicine
- Other Specialties Geriatric Medicine, Family Medicine
- Location Jacksonville, FL
- Active Since 04/26/2011
- Last Updated 12/23/2025
- Taxonomy Code 202D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972894921
Products in Payments
- Prolia (Biological) $174.59
- ELIQUIS (Drug) $51.13
- EVENITY (Biological) $35.23
- NUEDEXTA (Drug) $34.16
- Xembify (Biological) $34.03
- ENTRESTO (Drug) $33.78
- VRAYLAR (Drug) $23.81
- AMYVID (Drug) $19.62
- Nuedexta (Drug) $17.43
- CHANTIX (Drug) $11.66
- PREVNAR - 13 (Biological) $10.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.